The spray-as-you-go condom
was invented by Jan Vinzenz Krause from the German Institute for Condom Consultancy. Mr. Krause had come up the idea when considering the difficulties some people faced using old-fashioned latex condoms, and drew inspiration from spray-on plasters now used in medicine.
Krause's invention consists of a can-type device that sprays latex from all sides. "We call it the '360 degree procedure' — once round and from top to bottom. It's a bit like a car wash," he said.
From Pickholes' post, you can instantly know how it works:
The liquid condom comes in an aerosol can that you spray onto the organ in question. A few seconds later, the liquid solidifies into the familiar latex and forms a tight seal.
According to Gizmag, the spray-on-condom can is expected to reach market in 2008 for a price of around EUR 20 (US$27) and will offer around 20 applications. Replacement cartridges are expected to cost half the initial purchase price for the entire pack, and will be offered in different strengths and colours.
Can't wait for any longer? Don't hesitate to sign up as a beta tester!
The similar product might also be invented in Australia. But when Australian businessman named Ravi Narain boasted his invented 'invisible condom' could "offer a global solution to reduce and eventually stop the spread" of HIV, he and his former employer Citrofresh International were fined hundreds of thousands of dollars by the Australian Stock Exchange for the misleading statement.
Source: Safe Sex Made Easy With New Spray-On Condoms @ Fox
Over-the-counter (OTC) cold and cough remedies, with fruity flavors specifically marketed for kids, were originally believed safe and widely available in drugstores. But a new report from saftey experts within the Food and Drug Administration said that those syrup cough remedies might not be safe as they were thought. The review found 54 reported deaths from decongestants over the past four decades, most in children under the age of 2. So, now FDA recommended NO level of dosage for children under the age of two, "due to the lack of evidence of efficacy and safety concerns."
